Thinking about buying stock in Aurora Technology Acquisition Safety Shot Uber Technologies Verrica Pharmaceuticals or Recursion Pharmaceuticals

December 15, 2023 2:31pm

NEW YORK, Dec. 15, 2023 /PRNewswire/ — InvestorsObserver issues critical PriceWatch Alerts for ATAK, SHOT, UBER, VRCA, and RXRX.

To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.

  1. ATAK: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=ATAK&prnumber=202312150
  2. SHOT: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=SHOT&prnumber=202312150
  3. UBER: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=UBER&prnumber=202312150
  4. VRCA: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=VRCA&prnumber=202312150
  5. RXRX: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=RXRX&prnumber=202312150

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.

InvestorsObserver provides patented technology to some of the biggest names on Wall Street and creates world-class investing tools for the self-directed investor on Main Street. We have a wide range of tools to help investors make smarter decisions when investing in stocks or options.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-aurora-technology-acquisition-safety-shot-uber-technologies-verrica-pharmaceuticals-or-recursion-pharmaceuticals-302016729.html

SOURCE InvestorsObserver

FOR MORE INFORMATION, PLEASE CONTACT:

Investors:

Terry Kohler 
Chief Financial Officer
info@verrica.com

Kevin Gardner
LifeSci Advisors
kgardner@lifesciadvisors.com

Chris Calabrese
LifeSci Advisors
ccalabrese@lifesciadvisors.com